Conglomerates keenly interested in M&A of domestic pharmaceutical industries.

Most of the local conglomerates are keenly interested in the M&A of domestic drug companies in view of its competitiveness. In the public subscription for Hanil pharmaceutical company stakes, 2 to 3 domestic conglomerates showed their keen interests.

The M&A interests shown by such conglomerates focused only on the top 50 drug companies having attractive marketability with ethical product l...